KR
50
4
AIZ
66
3
MCK
59
3
INTC
40
3
MS
70
6
AIG
38
2
JNPR
62
2
R
61
2
HIG
51
4
GOOG
83
4
ITW
48
5
CMCSA
52
3
CHRW
54
3
JBHT
48
2
LOW
46
3
HBI
56
3
MSI
57
3
DAL
64
3
STI
35
14
AEE
56
5
KR
50
4
AIZ
66
3
MCK
59
3
INTC
40
3
MS
70
6
AIG
38
2
JNPR
62
2
R
61
2
HIG
51
4
GOOG
83
4
ITW
48
5
CMCSA
52
3
CHRW
54
3
JBHT
48
2
LOW
46
3
HBI
56
3
MSI
57
3
DAL
64
3
STI
35
14
AEE
56
5
Financhill
Back

Dr Reddy's Laboratories 10K Form

Buy
70

RDY
Dr Reddy's Laboratories

Last Price:
$15.67
Seasonality Move:
-0.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RDY News And Ratings

See the #1 stock for the next 7 days that we like better than RDY

RDY Financial Statistics

Sales & Book Value

Annual Sales: $3.4B
Cash Flow: $16.7M
Price / Cash Flow: 129.4
Annual Sales: $4.38
Price / Book: 3.58

Profitability

EPS (TTM): 0.46660
Net Income (TTM): $651.8M
Gross Margin: $2B
Return on Equity: 19.35%
Return on Assets: 14.21%

Dr Reddy's Laboratories Earnings Forecast

Key Dr Reddy's Laboratories Financial Ratios

  • The Gross Profit Margin over the past 24 years for RDY is 58.61%.
  • The Selling, General & Administrative Expenses for RDY have been equal to 27.65% of Gross Profit Margin.
  • The Research & Development expenses have been 8.19% of Revenue.
  • The Interest Expense is 3.07% of Operating Income.
  • The Net Earning history of RDY is 19.95% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 14 years.

Dr Reddy's Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RDY
CUSIP: 256135
Website: drreddys.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 1.92
Quick Ratio: 1.28

Price-to-Earnings

Trailing P/E Ratio: 19.42
Forward P/E Ratio: 19.72

RDY Technical Analysis vs Fundamental Analysis

Buy
70
Dr Reddy's Laboratories (RDY) is a Buy

Is Dr Reddy's Laboratories a Buy or a Sell?